Literature DB >> 11357960

Exercise intolerance in mitochondrial myopathy is not related to lactic acidosis.

J Vissing1, U Gansted, B Quistorff.   

Abstract

In a double-blinded, placebo-controlled, crossover study in seven mitochondrial myopathy patients (MM), we investigated whether lowering of lactate with dichloroacetate (DCA) can improve exercise tolerance and oxidative capacity in MM. DCA lowered plasma lactate at rest and during exercise (from 10.5 +/- 2.0 to 5.0 +/- 1.6 mM; p = 0.005) but did not improve maximal work load or VO2 in cycle exercise or phosphorous magnetic resonance spectroscopy (31P-MRS)-assessed indices of muscle oxidative metabolism. This indicates that lactate acidosis is not the primary cause of exercise intolerance in MM.

Entities:  

Mesh:

Year:  2001        PMID: 11357960

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

Review 1.  The elusive magic pill: finding effective therapies for mitochondrial disorders.

Authors:  Amy Goldstein; Lynne A Wolfe
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 2.  Treatment for mitochondrial disorders.

Authors:  Gerald Pfeffer; Kari Majamaa; Douglass M Turnbull; David Thorburn; Patrick F Chinnery
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

3.  Disruption of BCAA metabolism in mice impairs exercise metabolism and endurance.

Authors:  Pengxiang She; Yingsheng Zhou; Zhiyou Zhang; Kathleen Griffin; Kavitha Gowda; Christopher J Lynch
Journal:  J Appl Physiol (1985)       Date:  2010-02-04

Review 4.  Diagnosis and treatment of mitochondrial myopathies.

Authors:  Gerald Pfeffer; Patrick F Chinnery
Journal:  Ann Med       Date:  2011-08-25       Impact factor: 4.709

Review 5.  Development of pharmacological strategies for mitochondrial disorders.

Authors:  M Kanabus; S J Heales; S Rahman
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

6.  Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease.

Authors:  Matthew G D Bates; Jane H Newman; Djordje G Jakovljevic; Kieren G Hollingsworth; Charlotte L Alston; Pawel Zalewski; Jacek J Klawe; Andrew M Blamire; Guy A MacGowan; Bernard D Keavney; John P Bourke; Andrew Schaefer; Robert McFarland; Julia L Newton; Douglass M Turnbull; Robert W Taylor; Michael I Trenell; Gráinne S Gorman
Journal:  Int J Cardiol       Date:  2013-06-03       Impact factor: 4.164

7.  Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model.

Authors:  Benjamin Chatel; Sylvie Ducreux; Zeina Harhous; Nadia Bendridi; Isabelle Varlet; Augustin C Ogier; Monique Bernard; Julien Gondin; Jennifer Rieusset; Håkan Westerblad; David Bendahan; Charlotte Gineste
Journal:  Dis Model Mech       Date:  2021-09-15       Impact factor: 5.758

Review 8.  Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases.

Authors:  M Mancuso; C Angelini; E Bertini; V Carelli; G P Comi; C Minetti; M Moggio; T Mongini; S Servidei; P Tonin; A Toscano; G Uziel; M Zeviani; G Siciliano
Journal:  Neuromuscul Disord       Date:  2012-12       Impact factor: 4.296

9.  Side alternating vibration training in patients with mitochondrial disease: a pilot study.

Authors:  Christopher Newell; Barbara Ramage; Ion Robu; Jane Shearer; Aneal Khan
Journal:  Arch Physiother       Date:  2017-08-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.